Our News on Newswise

Newswise: 64b594db89532_ResearchInstituteDSC02135.jpg

Using AI to Speed Up Vaccine Development Against Disease X

CEPI to provide up to $4.98 USD million to Houston Methodist Research Institute-led consortium to use artificial intelligence for design of vaccines to fight diseases with pandemic potential. The project will support a consortium, led by HMRI, to...
18-Jul-2023 9:00 AM EDT Add to Favorites

Newswise: 647e16b832fcb_EHJExpandedHeartLongCovidEdited.jpg

New analysis shows COVID variant and severity of illness influence cardiac dysfunction, a key indicator of long COVID

Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID-19 infection, were more likely to experience heart issues associated with long COVID, according to a recent study published in the European...
5-Jun-2023 12:05 PM EDT Add to Favorites

Houston Methodist Hospital reaches 10,000 transplant milestone

Surgeons at Houston Methodist Hospital successfully completed its 10,000th organ transplant yesterday.
5-May-2023 2:35 PM EDT Add to Favorites

Newswise: 643f22b939f6b_CDC-vs-MathModelVax-BoosterDosingSkeds.JPG

Study suggests longer time between COVID-19 vaccines more effective for some

A recent Houston Methodist study may offer some guidance on when certain populations should get their next booster. A research team of computational medicine and data scientists from the Houston Methodist Research Institute predicted the immune...
18-Apr-2023 7:20 PM EDT Add to Favorites

Newswise: 64384888040ac_NDESdevice.jpeg

Implantable device shrinks pancreatic tumors

Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer - one of the most aggressive and difficult to treat cancers - by delivering immunotherapy directly into the tumor with a device that is smaller than a grain of...
13-Apr-2023 2:35 PM EDT Add to Favorites

Newswise: 64137f0b36d2e_HDLcholestrolclearing.png

Researchers discover way to reverse infertility by reducing HDL cholesterol

Houston Methodist scientists reversed infertility in sterile mice by reducing HDL cholesterol with a bacterial protein in a promising development that shows further evidence linking high cholesterol to female infertility. The researchers worked with...
16-Mar-2023 5:05 PM EDT Add to Favorites

Small Test Group Shows ALS Patients’ Own Cells May Provide a Safe Pathway to Slow or Halt Progression of the Deadly Degenerative Disease

Removing ALS (amyotrophic lateral sclerosis) patients’ own dysfunctional cells, fixing them, then putting them back in patients’ bodies is a safe, well tolerated process that has been shown to slow or halt disease progression in a small number...
5-Oct-2022 4:15 PM EDT Add to Favorites

Newswise: 633c3b19d3a3a_MITIEverseappimage.jpg

Houston Methodist enters the metaverse with launch of new MITIEverse™ app

Exploring the heart from the inside out is now possible with a new app from Houston Methodist.
4-Oct-2022 10:05 AM EDT Add to Favorites

See All News

Our Experts on Newswise

Surgeons Remove Grapefruit-Sized Tumor From Man’s Brain; Implant 3D Computer Generated Prosthetic Skull Piece

Patient Chris DeHart had a massive meningioma that required 9 surgeries and 3 surgical specialties to remove. He relied on a Houston Methodist 'dream team' of surgeons to solve his case.
27-Oct-2022 3:30 PM EDT

Houston Methodist expert notes COVID-19 precautions lead to historic drop in flu cases

A silver lining is emerging amid the COVID-19 pandemic. Influenza numbers are way down – 98 percent down, according to the CDC. Locally, during flu season last year, Houston Methodist’s system of eight hospitals saw 250 to 450 flu cases per...
2-Feb-2021 2:30 PM EST

See All Experts


U.S. News & World Report has named Houston Methodist Hospital the No. 1 hospital in Texas and among the top 20 hospitals in the nation. Houston Methodist's reputation for outstanding care, treatments and research attracts patients from Texas, the nation and around the world.

Our teams of surgeons, physicians, researchers and other experts collaborate to solve medicine’s biggest challenges and turn discoveries into new therapies and treatments. Our drive for innovation is rooted in the legacy created by world-renowned cardiac surgeon Dr. Michael E. DeBakey. He performed the first coronary artery bypass surgery in Texas, and pioneered surgical advances, which have become universal practices.

These days, Houston Methodist not only is well established as a leader in heart and vascular treatments, research and education based on DeBakey’s achievements and reputation, but also is known for spearheading breakthroughs in organ transplantation, orthopedics, cancer treatment and neurology and neuroscience.



Stefanie Asin
Public Relations Director
Corporate Communications



Gale Smith
Public Relations Manager
Research Institute, Center for Innovation,Gastroenterology/GI Surgery, Ophthalmology, Otolaryngology



Lisa Merkl
Senior Research Media Relations Editor
Research Institute



Patti Muck
Public Relations Program Manager
Neurological Institute, Emergency Medicine



Amy Rose
Senior Media Relations Specialist
Transplant Center, Orthopedics & Sports Medicine, General Surgery


(412) 613-1428

Daniel Brown
Senior Marketing & Communications Specialist
Houston Methodist Baytown Hospital





Donna Ramirez
Program Manager for National Reputation